IP Library Granted Patent US 12,359,191
Granted Patent B2
US 12,359,191 · App. 18/414,679 · Granted Jul 15, 2025

Polyanionic acids to improve recovery and minimize system loss

Inventors: Michael Donegan (Charlton, MA); Martin Gilar (Franklin, MA); Matthew Lauber (North Smithfield, RI); Scott Mccall (Smithfield, RI); Pamela Iraneta (Brighton, MA); Kerri Smith (Marlborough, MA)
Assignee: Waters Technologies Corporation
C12N15/101C12N15/113C12N2310/11C12N2310/315
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,359,191
App. No.
18/414,679
Granted
Jul 15, 2025
Kind
B2
Abstract

The present technology relates to a method of separating a sample comprising oligonucleotides. The method includes injecting a polyphosphonic acid at a concentration of between about 0.01 M to about 1 M into the sample comprising oligonucleotides. The method also includes flowing the sample and polyphosphonic acid through a liquid chromatography column and separating the oligonucleotides.

Claims (16)

1. A method of separating a sample comprising oligonucleotides comprising:

injecting a polyphosphonic acid at a concentration of between about 0.01 M to about 1 M into the sample comprising oligonucleotides;

flowing the sample and polyphosphonic acid through a liquid chromatography column; and

separating the oligonucleotides.

2. The method of claim 1 , wherein the concentration of polyphosphonic acid is between about 0.01 M to about 0.1 M.

3. The method of claim 2 , wherein the concentration of polyphosphonic acid is between about 20 mM to about 50 mM.

4. The method of claim 3 , wherein the concentration of polyphosphonic acid is between about 30 mM to about 40 mM.

5. The method of claim 1 , wherein between about 1 pg to about 1 mg of the polyphosphonic acid is injected into the sample.

6. The method of claim 1 , wherein the polyphosphonic acid is etidronic acid.

7. The method of claim 1 , wherein the polyphosphonic acid is nitrilotri (methylphosphonic acid).

8. The method of claim 1 , wherein walls of the liquid chromatography column are formed of metal.

9. The method of claim 1 , wherein the sample comprises phosphorylated oligonucleotides.

10. The method of claim 9 , wherein the phosphorylated oligonucleotides comprise nucleotides and at least one nucleotide is adenosine triphosphate.

11. The method of claim 1 , wherein the polyphosphonic acid is etidronic acid at pH of 8.5 and the oligonucleotide comprises nucleotides and at least one nucleotide is adenosine triphosphate.

12. The method of claim 1 , wherein the polyphosphonic acid is a bisphosphonic acid.

13. The method of claim 12 , wherein the bisphosphonic acid is selected from the group consisting of clodronic acid, pamidronic acid, alendronic acid, neridronic acid, and olpadronic acid.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 17, 2024
From: DONEGAN, MICHAEL; GILAR, MARTIN; LAUBER, MATTHEW; MCCALL, SCOTT; IRANETA, PAMELA; SMITH, KERRI
To: WATERS TECHNOLOGIES CORPORATION
Reel/Frame 066153/0232 →
Continuity (3)
Division 17112502 · Dec 4, 2020
Provisional Application 62944145 · Dec 5, 2019
Related Publication 20240240170A1 · Jul 18, 2024
References Cited (30)
US 5869152A · Colon · 1999 [cited by applicant]
US 6686035B2 · Jiang et al. · 2004 [cited by applicant]
US 7442299B2 · Lee et al. · 2008 [cited by applicant]
US 7562367B1 · Arad · 2009 [cited by applicant]
US 8658038B2 · Rustamov et al. · 2014 [cited by applicant]
US 9380520B2 · Lee et al. · 2016 [cited by applicant]
US 20120055860A1 · Wyndham · 2012 [cited by applicant]
US 20190091657A1 · Lawrence et al. · 2019 [cited by applicant]
US 20210171932A1 · Donegan et al. · 2021 [cited by applicant]
US 20220017887A1 · Donegan · 2022 [cited by examiner]
EP 3450972A1 · 2019 [cited by applicant]
GB 2445442A · 2008 [cited by applicant]
WO 199622299A1 · 1996 [cited by applicant]
WO 199729825A1 · 1997 [cited by applicant]
WO 199856797A1 · 1998 [cited by applicant]
WO 2003080834A2 · 2003 [cited by applicant]
WO 2006127973A2 · 2006 [cited by applicant]
WO 2007064809A2 · 2007 [cited by applicant]
WO 2010072821A1 · 2010 [cited by applicant]
WO 2011073235A1 · 2011 [cited by applicant]
WO 2017155848A1 · 2017 [cited by applicant]
WO 2017155870A1 · 2017 [cited by applicant]
WO 2017155884A1 · 2017 [cited by applicant]
WO 2017189357A2 · 2017 [cited by applicant]
WO 2019067637A1 · 2019 [cited by applicant]
WO 2020055922A1 · 2020 [cited by applicant]
Hsiao et al. Improved LC/MS Methods for the Analysis of Metal-Sensitive Analytes Using Medronic Acid as a Mobile Phase Additive. Anal. Chem. 90(2018): 9457-964. [cited by applicant]
Gilar et al. “Purification of crude DNA oligonucleotides by solid-phase extraction and reversed-phase high-performance liquid chromatography.” J. Chromatogr. A. 890(2000): 167-177. [cited by applicant]
International Search Report and Written Opinion issued in International Application No. PCT/IB2020/061554 dated Mar. 24, 2021. [cited by applicant]
Szabo et al. “High Performance Anion Exchange and Hydrophilic Interaction Liquid Chromatography Approaches for Comprehensive Mass Spectrometry-Based Characterization of the N-Glycome of a Recombinant Human Erythropoieti… [cited by applicant]